STOCK TITAN

IMMUNIC (IMUX) amendment shows 683 Capital exit filing and 3.4% beneficial stake

Filing Impact
(Moderate)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G/A

Rhea-AI Filing Summary

IMMUNIC, INC. files an Amendment No. 2 to a Schedule 13G/A noting an "exit filing" by certain reporting persons. The amendment states that, as of May 15, 2026, 683 Capital Partners, LP, 683 Capital Management, LLC and Ari Zweiman may be deemed to beneficially own 474,200 shares (including 229,200 exercisable warrants), representing 3.4% of the company's common stock. The filing cites 13,621,526 shares outstanding as of April 28, 2026 as the base for the percentage calculation and includes the verbatim comment that the Reporting Persons "no longer beneficially own more than five percent" of the issuer.

Positive

  • None.

Negative

  • None.

Insights

Ownership drop below 5% via exit filing; holdings remain disclosed.

The filing records that the Reporting Persons may be deemed to beneficially own 474,200 shares, comprising 245,000 directly held shares and 229,200 exercisable warrants, equal to 3.4% on the stated outstanding base of 13,621,526 shares as of April 28, 2026.

Because the schedule is an exit amendment, it documents a reduction in reported stake below the 5% reporting threshold; cash‑flow treatment or specific transactions causing the reduction are not described in the excerpt.

Amendment frames a compliance update rather than a market action.

The document is structured to satisfy beneficial‑ownership disclosure requirements, including shared voting/dispositive power figures for the three Reporting Persons and an explanatory comment that this filing "constitutes an exit filing." The percentage calculation explicitly includes currently exercisable warrants.

Subsequent filings would be required if holdings cross the 5% threshold again; the excerpt does not state any planned trades or transfers.

Total deemed beneficial ownership 474,200 shares As of May 15, 2026 (includes exercisable warrants)
Directly held shares 245,000 shares Beneficially owned by 683 Capital Partners, LP as of May 15, 2026
Exercisable warrants 229,200 warrants Warrants exercisable and counted toward beneficial ownership as of May 15, 2026
Shares outstanding used for calc 13,621,526 shares Outstanding as of April 28, 2026 (base for percentage)
Percent of class 3.4% Reported beneficial ownership percentage including exercisable warrants
beneficially own regulatory
"This Amendment No. 2 constitutes an exit filing for the Reporting Persons"
Beneficially own means having the economic rights and risks of a security—such as the right to receive dividends, sell the shares, or profit from price changes—whether or not your name appears on the official share register. Think of it like renting a car: you use it and reap the benefits even if the title lists someone else. Investors care because beneficial ownership determines who truly controls value, must be disclosed under securities rules, and can signal potential influence or trading activity that affects a stock’s price.
exercisable warrants financial
"warrants to purchase an additional 229,200 shares of Common Stock which are currently exercisable"
exit filing regulatory
"This Amendment No. 2 constitutes an exit filing for the Reporting Persons"





4525EP200

(CUSIP Number)
03/31/2026

(Date of Event Which Requires Filing of this Statement)


Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G




Comment for Type of Reporting Person: This Amendment No. 2 constitutes an exit filing for the Reporting Persons (as defined below), as the Reporting Persons no longer beneficially own more than five percent of the outstanding shares of the Issuer.


SCHEDULE 13G




Comment for Type of Reporting Person: This Amendment No. 2 constitutes an exit filing for the Reporting Persons (as defined below), as the Reporting Persons no longer beneficially own more than five percent of the outstanding shares of the Issuer.


SCHEDULE 13G




Comment for Type of Reporting Person: This Amendment No. 2 constitutes an exit filing for the Reporting Persons (as defined below), as the Reporting Persons no longer beneficially own more than five percent of the outstanding shares of the Issuer.


SCHEDULE 13G



683 CAPITAL MANAGEMENT, LLC
Signature:/s/ Ari Zweiman
Name/Title:Ari Zweiman, Managing Member
Date:05/15/2026
683 CAPITAL PARTNERS, LP
Signature:/s/ Ari Zweiman
Name/Title:Ari Zweiman, Authorized Person
Date:05/15/2026
Zweiman Ari
Signature:/s/ Ari Zweiman
Name/Title:Ari Zweiman, Self
Date:05/15/2026

FAQ

What does IMMUNIC (IMUX) Amendment No. 2 report about 683 Capital's stake?

It reports that 683 Capital and related persons may be deemed to beneficially own 474,200 shares, including 229,200 exercisable warrants, representing 3.4% of the class on the disclosed basis.

How is the 3.4% ownership percentage calculated in the filing?

The percentage is based on 13,621,526 shares outstanding as of April 28, 2026, plus 229,200 shares issuable upon exercise of currently exercisable warrants held by the Reporting Persons.

Which entities and individual are named as Reporting Persons in the Schedule 13G/A?

The filing names 683 Capital Management, LLC, 683 Capital Partners, LP, and Ari Zweiman as the Reporting Persons and provides their principal business address in New York.

Does the amendment explain how the stake fell below 5%?

No. The filing states it "constitutes an exit filing" because the Reporting Persons "no longer beneficially own more than five percent," but it does not describe the specific transactions or cash flows that produced the change.

Are warrants included in the beneficial‑ownership count in this filing?

Yes. The filing explicitly includes 229,200 currently exercisable warrants in the total deemed beneficial ownership of 474,200 shares as of May 15, 2026.